Literature DB >> 17665978

Targeting mitochondria in the treatment of human cancer: a coordinated attack against cancer cell energy metabolism and signalling.

Hanne Hagland1, Julie Nikolaisen, Linn I Hodneland, Bjøorn T Gjertsen, Øystein Bruserud, Karl J Tronstad.   

Abstract

Mitochondria have major roles in bioenergetics and vital signalling of the mammalian cell. Consequently, these organelles have been implicated in the process of carcinogenesis, which includes alterations of cellular metabolism and cell death pathways. Multiple molecular routes of malignant transformation appear to result in the common ability of many tumours to take up large amounts of glucose. This metabolic twist has been explained by phenomena such as aerobic glycolysis and impaired mitochondrial function, and is linked to tumour growth potential via major cellular signalling pathways. This paper reviews the literature on central mechanisms through which energy metabolism merges with growth, proliferation and death signalling, which tend to include mitochondria at some level. These processes can potentially be targeted by pharmacological agents for therapeutic and chemosensitising purposes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17665978     DOI: 10.1517/14728222.11.8.1055

Source DB:  PubMed          Journal:  Expert Opin Ther Targets        ISSN: 1472-8222            Impact factor:   6.902


  13 in total

1.  Targeting mitochondria by α-tocopheryl succinate kills neuroblastoma cells irrespective of MycN oncogene expression.

Authors:  Björn Kruspig; Azadeh Nilchian; Ignacio Bejarano; Sten Orrenius; Boris Zhivotovsky; Vladimir Gogvadze
Journal:  Cell Mol Life Sci       Date:  2012-06       Impact factor: 9.261

2.  The angiogenic switch leads to a metabolic shift in human glioblastoma.

Authors:  Krishna M Talasila; Gro V Røsland; Hanne R Hagland; Eskil Eskilsson; Irene H Flønes; Sabrina Fritah; Francisco Azuaje; Nadia Atai; Patrick N Harter; Michel Mittelbronn; Michael Andersen; Justin V Joseph; Jubayer Al Hossain; Laurent Vallar; Cornelis J F van Noorden; Simone P Niclou; Frits Thorsen; Karl Johan Tronstad; Charalampos Tzoulis; Rolf Bjerkvig; Hrvoje Miletic
Journal:  Neuro Oncol       Date:  2017-03-01       Impact factor: 12.300

3.  Hyperoxic treatment induces mesenchymal-to-epithelial transition in a rat adenocarcinoma model.

Authors:  Ingrid Moen; Anne Margrete Øyan; Karl-Henning Kalland; Karl Johan Tronstad; Lars Andreas Akslen; Martha Chekenya; Per Øystein Sakariassen; Rolf Kåre Reed; Linda Elin Birkhaug Stuhr
Journal:  PLoS One       Date:  2009-07-28       Impact factor: 3.240

4.  Proline oxidase functions as a mitochondrial tumor suppressor in human cancers.

Authors:  Yongmin Liu; Gregory L Borchert; Steven P Donald; Bhalchandra A Diwan; Miriam Anver; James M Phang
Journal:  Cancer Res       Date:  2009-08-04       Impact factor: 12.701

5.  How close is the bench to the bedside? Metabolic profiling in cancer research.

Authors:  Que N Van; Timothy D Veenstra
Journal:  Genome Med       Date:  2009-01-20       Impact factor: 11.117

Review 6.  Targeting mitochondria as therapeutic strategy for metabolic disorders.

Authors:  Daniela Sorriento; Antonietta Valeria Pascale; Rosa Finelli; Anna Lisa Carillo; Roberto Annunziata; Bruno Trimarco; Guido Iaccarino
Journal:  ScientificWorldJournal       Date:  2014-03-13

7.  Automated quantification and integrative analysis of 2D and 3D mitochondrial shape and network properties.

Authors:  Julie Nikolaisen; Linn I H Nilsson; Ina K N Pettersen; Peter H G M Willems; James B Lorens; Werner J H Koopman; Karl J Tronstad
Journal:  PLoS One       Date:  2014-07-02       Impact factor: 3.240

Review 8.  Metabolic alterations in cancer cells and therapeutic implications.

Authors:  Naima Hammoudi; Kausar Begam Riaz Ahmed; Celia Garcia-Prieto; Peng Huang
Journal:  Chin J Cancer       Date:  2011-08

9.  Gene expression profiling of the tumor microenvironment during breast cancer progression.

Authors:  Xiao-Jun Ma; Sonika Dahiya; Elizabeth Richardson; Mark Erlander; Dennis C Sgroi
Journal:  Breast Cancer Res       Date:  2009-02-02       Impact factor: 6.466

10.  ROS-mediated EB1 phosphorylation through Akt/GSK3β pathway: implication in cancer cell response to microtubule-targeting agents.

Authors:  Marion Le Grand; Amandine Rovini; Veronique Bourgarel-Rey; Stephane Honore; Sonia Bastonero; Diane Braguer; Manon Carre
Journal:  Oncotarget       Date:  2014-05-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.